Case Study: Immunomic Therapeutics achieves secure control of confidential corporate information and faster deal-making with SecureDocs Virtual Data Room

Using a SecureDocs Virtual Data Room to Manage the Business Process Behind a Deal

Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company developing the LAMP-Vax vaccine platform, faced the challenge of sharing highly sensitive R&D and business documentation with potential corporate partners without risking loss of control or leaking IP. To support secure, professional due diligence, ITI selected SecureDocs and deployed the SecureDocs Virtual Data Room to manage access to critical materials.

SecureDocs provided a purpose-built virtual data room with strict access controls (view-only/no-download, custom roles), audit logs, NDA protections, and a simple drag-and-drop interface, all at an affordable flat rate. Using SecureDocs, ITI streamlined document sharing, gained full transparency into who accessed materials, improved alliance and committee governance, and supported ongoing due diligence—culminating in successful partnering activities including a $70MM licensing deal while using the SecureDocs platform.

Immunomic Therapeutics

Colin Magowan

Director of Business Development